A Phase 2 Multicenter Single Arm Clinical Trial of ABX EGF (Panitumumab) Monotherapy in Japanese Subjects With Metastatic Colorectal Cancer Who Developed Progressive Disease or Relapsed While on or After Prior Fluoropyrimidine, Irinotecan and Oxaliplatin Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2009
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Amgen
- 22 Sep 2009 Actual patient number (50) added as reported by ClinicalTrials.gov.
- 22 Oct 2006 New trial record.